Family Care Hospitals Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	3yrs

Recente managementupdates

Recent updates

CEO

Family Care Hospitals heeft geen CEO, of we hebben geen gegevens over hen.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Pandoo Naig	MD & Executive Director	4.2yrs	geen gegevens	geen gegevens
Dhananjay Parikh	Non Executive-Independent Director	4.2yrs	geen gegevens	geen gegevens
Suryakant Khare	Non Executive Non Independent Director	2.3yrs	geen gegevens	geen gegevens
Lucy Massey	Non-Executive Non-Independent Director	3yrs	geen gegevens	geen gegevens
Aneish Kumar	Non Executive Independent Director	2.3yrs	geen gegevens	geen gegevens

3.0yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 516110 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).

Family Care Hospitals Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Family Care Hospitals Limited, Annual General Meeting, Sep 30, 2024

Family Care Hospitals Limited Announces Resignation of Pankaj Samani as Non Executive Independent Director

Family Care Hospitals Limited, Annual General Meeting, Sep 29, 2023

Family Care Hospitals Limited Approves the Appointment of Mohini Waghade as Company Secretary and Compliance Officer

Family Care Hospitals Limited Announces Resignation of Company Secretary / Compliance Officer

High number of new and inexperienced directors

Recent updates

New major risk - Revenue and earnings growth

Family Care Hospitals Limited to Report Q2, 2025 Results on Nov 12, 2024

Investor sentiment improves as stock rises 20%

Family Care Hospitals Limited, Annual General Meeting, Sep 30, 2024

First quarter 2025 earnings released: EPS: ₹0.04 (vs ₹0.25 in 1Q 2024)

Family Care Hospitals Limited to Report Q1, 2025 Results on Aug 13, 2024

Family Care Hospitals Limited Announces Resignation of Pankaj Samani as Non Executive Independent Director

Full year 2024 earnings released: EPS: ₹2.32 (vs ₹0.97 in FY 2023)

Family Care Hospitals Limited to Report Q4, 2024 Results on May 28, 2024

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Family Care Hospitals Limited announced that it expects to receive INR 50 million in funding from Jeevan Jyoti Vanijya Ltd, Parklight Securities Private Limited, Shree Bhuvanakaram Tradinvest Private Ltd, Shree Mallikarjun Tradinvest Pvt Ltd and other investors

Family Care Hospitals Limited announced that it expects to receive INR 50 million in funding from Jeevan Jyoti Vanijya Ltd, Parklight Securities Private Limited, Shree Bhuvanakaram Tradinvest Private Ltd, Shree Mallikarjun Tradinvest Pvt Ltd and other investors

Family Care Hospitals Limited announced that it expects to receive INR 50 million in funding from Jeevan Jyoti Vanijya Ltd, Parklight Securities Private Limited, Shree Bhuvanakaram Tradinvest Private Ltd, Shree Mallikarjun Tradinvest Pvt Ltd and other investors

Third quarter 2024 earnings released: EPS: ₹0.21 (vs ₹0.37 in 3Q 2023)

Family Care Hospitals Limited to Report Q3, 2024 Results on Jan 31, 2024

Investor sentiment improves as stock rises 25%

Second quarter 2024 earnings released: EPS: ₹0.23 (vs ₹0.45 in 2Q 2023)

Family Care Hospitals Limited to Report Q2, 2024 Results on Oct 27, 2023

Investor sentiment improves as stock rises 16%

Family Care Hospitals Limited, Annual General Meeting, Sep 29, 2023

First quarter 2024 earnings released: EPS: ₹0.25 (vs ₹0.41 in 1Q 2023)

Family Care Hospitals Limited Approves the Appointment of Mohini Waghade as Company Secretary and Compliance Officer

Family Care Hospitals Limited to Report Q1, 2024 Results on Aug 11, 2023

Investor sentiment deteriorates as stock falls 31%

Full year 2023 earnings released: EPS: ₹0.16 (vs ₹1.62 in FY 2022)

Investor sentiment improves as stock rises 19%

Family Care Hospitals Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹0.37 (vs ₹0.42 in 3Q 2022)

Family Care Hospitals Limited to Report Q3, 2023 Results on Feb 13, 2023

Investor sentiment improved over the past week

Family Care Hospitals Limited Announces Resignation of Company Secretary / Compliance Officer

Upcoming dividend of ₹0.05 per share

Second quarter 2023 earnings released: EPS: ₹0.45 (vs ₹0.40 in 2Q 2022)

High number of new and inexperienced directors

Family Care Hospitals Limited Approves Interim Dividend for the Financial Year 2022-23

Family Care Hospitals Limited to Report Q2, 2023 Results on Nov 14, 2022

High number of new and inexperienced directors

Family Care Hospitals Limited Approves Board Appointments

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Scandent Imaging Limited Approves Dividend for the Financial Year Ended March 31, 2022

Investor sentiment deteriorated over the past week

Scandent Imaging Limited Announces the Regulation of Rajeev Singh as Non Executive and Non Independent Director

Scandent Imaging Limited Appoints Sapna Vaishnav as Company Secretary and Compliance Officer

Scandent Imaging Limited, Annual General Meeting, Jul 28, 2022

Full year 2022 earnings released: EPS: ₹1.62 (vs ₹1.27 in FY 2021)

Scandent Imaging Limited to Report Q1, 2023 Results on Jul 09, 2022

Scandent Imaging Limited Proposes Dividend for the Year Ended March 31, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

High number of new and inexperienced directors

Investor sentiment improved over the past week

High number of new and inexperienced directors

Second quarter 2022 earnings released: EPS ₹0.40 (vs ₹0.38 in 2Q 2021)

High number of new and inexperienced directors

Non-Executive Non Independent Director Rahul Sathe has left the company

High number of new directors

First quarter 2022 earnings released: EPS ₹0.47 (vs ₹0.30 in 1Q 2021)

Investor sentiment deteriorated over the past week